Shares of Catalyst Pharmaceuticals rose 4.82% to $3.81 at 11:06 EST on Monday, after two consecutive sessions in a row of gains. The Nasdaq Stock Market is rising 1.27% to $12,535.60, following yesterday’s downward trend, This seems, up until now, an all-around positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $3.63, 38.76% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the current quarter and 4.6% for the next. The company’s growth estimates for the current quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals’s stock is valued at $3.81 at 11:06 EST, way below its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is way higher than its 50-day moving average of $3.37 and higher than its 200-day moving average of $3.79.

LEAVE A REPLY

Please enter your comment!
Please enter your name here